Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
about
Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVEndocrine-disrupting chemicals and fatty liver disease.Recent advances in hepatocellular carcinoma therapy.Cellular senescence drives age-dependent hepatic steatosis.Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012.A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesProjections of primary liver cancer to 2030 in 30 countries worldwide.Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies.The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis.Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era.Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells.Non-alcoholic Fatty Liver Disease: A Clinical Update.E2F1, a Novel Regulator of Metabolism.Waist-to-hip ratio but not body mass index predicts liver cirrhosis in women.Current topics in the surgical treatments for hepatocellular carcinoma.Non-alcoholic fatty liver diseaseHepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9)Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
P2860
Q26750865-34472064-E220-419C-824E-A2FA37BCC67BQ28079826-56FE3035-8976-4C3A-8834-F270C17C3501Q30234414-135E8DB0-D326-4925-A6CE-FFA0D30A68F5Q30236010-8AE03B6F-46BD-45F8-80F4-35865C8654F6Q33810220-3D0B6242-43CE-4777-B22E-DE94AECE8203Q37644945-B4EA0247-13DA-4320-8C39-35F09CE19C9DQ37703437-6765D911-404C-4407-B834-D201CE5BB159Q38634903-F06D58B7-8C2F-46E7-9F62-218B0CB78903Q40048235-DA1A0FAE-0AFA-49CC-BA69-1E8173713A62Q41974093-DE579218-5A16-4EA2-AED9-C6E422A05534Q44761183-3E12BD85-618F-43CD-B6D4-D50DDECA1195Q47094698-35D2638C-7BE4-469D-9242-8F67B93BA3D1Q47100244-20054E91-5DF1-4483-A66C-AAFBBC8CAF9DQ47119185-3B2BA71E-8FF1-48F4-8204-C00C5A68A1D0Q47569882-8517206F-9CEC-4F13-A9A2-BA2463DB8989Q55322423-DC07BB32-9505-4955-8D14-EA119BA8F1D6Q56003593-C8F8ED94-EF84-4B26-8779-110BD957AB5BQ58553684-3A0F7446-29E3-4559-AC3C-0135F679F043Q58804230-D5145A4A-2C8D-43CB-8AF4-6B0AFAF1C486
P2860
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
@en
type
label
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
@en
prefLabel
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
@en
P2860
P1476
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
@en
P2093
Christopher P Day
Helen L Reeves
P2860
P2888
P304
P356
10.1007/S10620-016-4085-6
P577
2016-02-26T00:00:00Z
P6179
1001657946